Skip to main content
Premium Trial:

Request an Annual Quote

PathwayAssist 2.0, FGENESH, Screener, Bioperl 1.2.3, Bioperl-Microarray


Ariadne Genomics has released PathwayAssist 2.0, desktop software for visualization and analysis of cell signaling pathways, molecular networks, and protein-protein interaction data from experiments and literature. A free, 20-day trial is available at PathwayAssist comes with a MedScan module for automated extraction of information from scientific literature, and ResNet, a molecular networks database compiled from Medline abstracts and other public data sources. New features include Build Pathway tools to find functional associations between genes derived from microarray experiments, and database importers for KEGG, BIND, DIP, and GO.

Softberry has released a new parameter set for gene annotation in fish, diatom, and Aspergillus genomes for its FGENESH ab initio gene prediction software at

Oak Ridge National Laboratory has released genes predicted using the GrailExp software program for NCBI human build 33 at

Genedata has released version 2.0 of its Screener software for high-throughput screening and pharmacological profiling data. The new release extends coverage of screening workflow by incorporating the analysis of hit confirmation screens, dose-response-, and high-content assays.

Bioperl 1.2.3 is now available at The release contains minor functionality improvements and several bugfixes from the 1.2.2 release. The next set of developer’s releases for Bioperl, to be numbered 1.3.x, are planned for the fall of 2003.

The Bioperl project has also released version 0.1 of Bioperl-Microarray, an extension package for manipulating microarray data. It currently supports Affymetrix GeneChip CEL, CDF, Microarray Suite 5.0, and dChip files. Support is planned for Bio::MAGE objects and MAGE-ML, Affymetrix SNPChip genotype files, and GenePix GPR files for version 0.2. The release package is available at

Filed under

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.